{"id":140458,"title":"Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series: NACI, June 16, 2023 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T14:13:31.966000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-interim-guidance-use-bivalent-omicron-containing-covid-19-vaccines-primary-series.html?wbdisable=true","snippet":"Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series: NACI, June 16, 2023 - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu…","rawSnapshotUrl":"/api/snapshots/raw/140458","browseUrl":"https://replay.healtharchive.ca/job-1/20250418141331/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-interim-guidance-use-bivalent-omicron-containing-covid-19-vaccines-primary-series.html?wbdisable=true#ha_snapshot=140458","mimeType":"text/html","statusCode":200}